David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Meritage Homes
MTH
$4.71B
| $6.61M | 0.01% |
295,858
-147,964
| -33% | -$3.17M |
|
|
ISBC
1327
DELISTED
Investors Bancorp, Inc.
ISBC
| $6.61M | 0.01% |
558,141
+81,767
| +17% | +$986K |
|
1328
Option Care Health
OPCH
$3.6B
| $6.61M | 0.01% |
826,146
-121,749
| -13% | -$1.6M |
|
1329
CALL
Vail Resorts
MTN
$5.3B
| $6.61M | 0.01% |
30,400
-19,100
| -39% | -$3.9M |
|
1330
First Citizens BancShares
FCNCA
$24.6B
| $6.61M | 0.01% |
16,221
+5,332
| +49% | +$2.21M |
|
1331
Annaly Capital Management
NLY
$17.2B
| $6.6M | 0.01% |
165,081
+117,730
| +249% | +$4.8M |
|
|
GG
1332
DELISTED
Goldcorp Inc
GG
| $6.59M | 0.01% |
576,177
+120,759
| +27% | +$1.3M |
|
|
FLY
1333
DELISTED
Fly Leasing Limited
FLY
| $6.58M | 0.01% |
475,129
+18,961
| +4% | +$224K |
|
|
CONE
1334
DELISTED
CyrusOne Inc Common Stock
CONE
| $6.56M | 0.01% |
+125,144
| New | +$6.55M |
|
1335
Sixth Street Specialty
TSLX
$1.79B
| $6.56M | 0.01% |
327,896
+171,401
| +110% | +$3.39M |
|
1336
Cohu
COHU
$2.42B
| $6.54M | 0.01% |
443,419
+57,606
| +15% | +$982K |
|
1337
Takeda Pharmaceutical
TAK
$58.2B
| $6.52M | 0.01% |
+319,983
| New | +$6.44M |
|
1338
The Bancorp
TBBK
$2.7B
| $6.52M | 0.01% |
806,606
+69,448
| +9% | +$600K |
|
1339
PUT
Lear
LEA
$8.28B
| $6.51M | 0.01% |
48,000
+4,700
| +11% | +$689K |
|
1340
CALL
Truist Financial
TFC
$61.9B
| $6.51M | 0.01% |
+140,000
| New | +$6.83M |
|
|
UN
1341
DELISTED
Unilever NV New York Registry Shares
UN
| $6.51M | 0.01% |
111,671
+78,852
| +240% | +$4.33M |
|
1342
Nomad Foods
NOMD
$1.7B
| $6.5M | 0.01% |
318,006
+302,896
| +2,005% | +$5.82M |
|
|
AMRN
1343
Amarin Corp
AMRN
$304M
| $6.49M | 0.01% |
15,636
+8,823
| +130% | +$3.18M |
|
1344
Emcor
EME
$33.7B
| $6.48M | 0.01% |
88,628
-53,099
| -37% | -$3.6M |
|
1345
Mueller Water Products
MWA
$3.95B
| $6.44M | 0.01% |
641,591
+294,935
| +85% | +$2.97M |
|
|
ABMD
1346
PUT
DELISTED
Abiomed Inc
ABMD
| $6.43M | 0.01% |
22,500
-27,900
| -55% | -$9.27M |
|
|
EIGI
1347
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $6.42M | 0.01% |
886,111
+239,174
| +37% | +$1.74M |
|
1348
CALL
Essex Property Trust
ESS
$18.5B
| $6.42M | 0.01% |
+22,200
| New | +$6.06M |
|
|
BAND
1349
Bandwidth Inc
BAND
$1.51B
| $6.38M | 0.01% |
95,250
+88,450
| +1,301% | +$4.65M |
|
1350
PUT
Carnival Corporation Ltd
CCL
$35B
| $6.33M | 0.01% |
124,800
+116,200
| +1,351% | +$6.44M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.